The increase in price target from $95 to $120 by UBS analyst Chris Snyder, while maintaining a Neutral rating, suggests a positive outlook on the stock's value without changing its investment rating. This adjustment reflects an expectation of higher stock performance in the short term, likely leading to increased investor interest and potentially a positive impact on the stock price.